EN Lynch, FP Russo - Journal of Clinical Medicine, 2023 - mdpi.com
Treatment of hepatitis C (HCV) has been revolutionized with the introduction of direct-acting antivirals (DAAs). Patients can be treated at more advanced stages of liver disease, with a …
P Sharma, R Sawtell, Q Wang, ME Sise - Advances in Kidney Disease and …, 2023 - Elsevier
Treatment of chronic hepatitis C virus (HCV) and hepatitis B virus (HBV) infection poses unique challenges in patients with kidney disease. Direct-acting antivirals have been a …
(1) Background. Hepatitis C infection often leads to extrahepatic manifestations, including cryoglobulinemic vasculitis. This systematic review aimed to assess the efficacy and safety …
N Méndez-Sánchez, CE Coronel-Castillo… - Pathogens, 2024 - mdpi.com
Chronic hepatitis C virus infection is an important cause of liver cirrhosis, hepatocellular carcinoma and death. Furthermore, it is estimated that about 40–70% of patients develop …
A Sohal, C Singh, A Bhalla, H Kalsi… - Journal of Clinical …, 2024 - pmc.ncbi.nlm.nih.gov
Hepatitis C virus (HCV) has emerged as a major global health concern and, if left untreated, can lead to significant liver damage, including cirrhosis, decompensated liver disease, and …
M Jovanovic, M Sabovic - Journal of Medical Case Reports, 2023 - Springer
Background Clopidogrel and ticagrelor are rarely reported to cause vasculitis via drug hypersensitivity reaction, largely mediated by T cells and immunoglobulin E (IgE). Despite …
Las vasculitis de pequeño vaso mediadas por inmunocomplejos son un grupo de vasculitis en las que la afectación cutánea puede ser la primera manifestación clínica. En este grupo …
K Yokoyama, T Kino, T Nagata, T Miyayama… - Internal …, 2023 - jstage.jst.go.jp
We herein report a case of hepatitis C virus (HCV)-associated cryoglobulinemic livedo reticularis in a woman in her 60s that improved with direct-acting antivirals (DAAs) …